Johnson & Johnson (JNJ) Stock Analysis: AI Score & Alternative Data
JNJ alt-data: revenue climbing, web traffic lagging
Is Johnson & Johnson a buy right now? The alternative data says hold. This JNJ stock analysis is built on the 25+ alternative data signals AltIndex tracks on Johnson & Johnson every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 57/100: a Hold. The stock trades at $256.98 with a $624B market cap.
The bullish side of the 90-day ledger: revenue up 9.9% YoY to $24.1B, headcount (according to LinkedIn) up 11.8% to 133K employees, and 70% of employees are positive on the business outlook. The drag: web traffic down 13.9% to 2.3M monthly visits, job postings down 10.3% to 399 open roles, and Reddit mentions down 83.3% to 1 a day. That tension is what keeps the score mid-range.
JNJ’s broader alt-data profile also covers Facebook followers (1.1M), and sentiment (85/100). Every signal links to its own page with full history, the JNJ technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on JNJ is just below.
Johnson & Johnson AI Stock Analysis
Johnson & Johnson (JNJ) is one of the largest and most diversified healthcare companies in the world. With operations spanning pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson serves millions of customers globally.
Analysis generated July 2, 2026.
Recent Johnson & Johnson Stock Alerts
![]() |
Johnson & Johnson | July 7 Lloyd Doggett (member of U.S. congress) is buying shares |
![]() |
Johnson & Johnson | June 15 Ro Khanna (member of U.S. congress) is selling shares |
![]() |
Johnson & Johnson | June 13 Insider Alert: Wengel Kathryn E is selling shares |
![]() |
Johnson & Johnson | June 4 Over the past few months, there has been a noticeable downward trend in Job postings. |
Johnson & Johnson Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 2.3M | 13.9% | |
| Job Posts | 399 | 10.3% | |
| LinkedIn Employees | 133K | 11.8% | |
| Wikipedia Views | 1K | 51.0% | |
| Employee Recommend | 80 | 1.2% | |
| Business Outlook | 70 | 1.4% | |
| Lobbying Cost | $503K | 0% | |
| Sentiment | 85 | 0% | |
| Reddit Mentions | 1 | 83.3% | |
| X Mentions | 16 | 1,500.0% | |
| Stocktwits Mentions | 99 | 83.3% | |
| News Mentions | 4 | N/A | |
| Stocktwits Subscribers | 49K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 242K | 0% | |
| Instagram Followers | 116K | 1.9% | |
| Youtube Subscribers | 75K | 0% | |
| Facebook Followers | 1.1M | 0% | |
| Facebook Engagement | 602 | 47.5% |
About Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
| Price | $256.98 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $624B |
| Year Range | $153 – $267 |
| Dividend Yield | 0% |
| PE Ratio | 30.5 |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Johnson & Johnson News
View more →![]() |
Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One WinnerJuly 10 - Biztoc.com |
Jim Cramer Says Johnson & Johnson “Will Have Lots of Good News About Its Myriad Blockbuster Drugs”July 9 - Yahoo Entertainment |
|
![]() |
Johnson & Johnson’s DE STSF platform secures FDA approvalJuly 9 - Biztoc.com |
[SnS, AC] $5.35* | 80-Piece Johnson & Johnson Travel Ready Portable Emergency First Aid Kit at AmazonJuly 8 - Slickdeals.net |
|
[SnS, AC] $6.04* | 80-Piece Johnson & Johnson Travel Ready Portable Emergency First Aid Kit at AmazonJuly 8 - Slickdeals.net |
Johnson & Johnson Earnings & Financial Performance
View all earnings →Johnson & Johnson Insider Trading Activity
View all →| Wengel Kathryn E filed to sell 114,288 shares at $0.0. Jun 11 '26 |
| Decker Robert J filed to sell 23,682 shares at $0.0. Feb 27 '26 |
| Schmid Timothy filed to sell 25,447 shares at $0.0. Feb 20 '26 |
| Schmid Timothy filed to sell 26,769 shares at $0.0. Feb 18 '26 |
| Schmid Timothy filed to sell 26,769 shares at $0.0. Feb 18 '26 |
Johnson & Johnson Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Lloyd Doggett |
Jul 7, 26 | Buy | $8K+ |
| Ro Khanna |
Jun 11, 26 | Sell | $8K+ |
| Thomas H. Kean |
Apr 14, 26 | Sell | $8K+ |
| John Boozman |
Apr 14, 26 | Sell | $8K+ |
| Ro Khanna |
Apr 9, 26 | Sell | $8K+ |
Stocks Similar to Johnson & Johnson
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
![]() |
AbbVieABBV |
$248.08 0.7% | $442B | 70 |
![]() |
Merck & CompanyMRK |
$123.54 1.2% | $309B | 62 |
![]() |
AstrazenecaAZN |
$171.61 3.9% | $269B | 46 |
![]() |
Novo NordiskNVO |
$49.48 1.2% | $216B | 73 |
![]() |
Eli Lilly and CompanyLLY |
$1,188.58 2.3% | $1.08T | 78 |
Explore Johnson & Johnson Data
Frequently Asked Questions: Johnson & Johnson (JNJ)
Johnson & Johnson has an AltIndex AI Score of 57/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
57/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Johnson & Johnson (JNJ) stock is $256.98 with a market cap of $624B.
As of today, Johnson & Johnson’s PE (Price to Earnings) ratio is 30.5.
View the latest Johnson & Johnson insider transactions to see recent buying and selling activity by company executives and directors.
Check the Johnson & Johnson congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The JNJ stock price chart above shows Johnson & Johnson’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Johnson & Johnson technical analysis for RSI, moving averages, and more.
See the stocks similar to Johnson & Johnson section on this page for companies in the same industry ranked by market cap and AI Score.






